Agios Pharmaceuticals (AGIO) Research & Development: 2012-2025
Historic Research & Development for Agios Pharmaceuticals (AGIO) over the last 14 years, with Sep 2025 value amounting to $86.8 million.
- Agios Pharmaceuticals' Research & Development rose 19.79% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.3 million, marking a year-over-year increase of 12.95%. This contributed to the annual value of $301.3 million for FY2024, which is 1.95% up from last year.
- Per Agios Pharmaceuticals' latest filing, its Research & Development stood at $86.8 million for Q3 2025, which was down 5.59% from $91.9 million recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Research & Development registered a high of $91.9 million during Q2 2025, and its lowest value of $57.7 million during Q1 2021.
- Moreover, its 3-year median value for Research & Development was $77.4 million (2024), whereas its average is $77.1 million.
- Data for Agios Pharmaceuticals' Research & Development shows a peak YoY increase of 243.96% (in 2021) and a maximum YoY decrease of 36.81% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Research & Development stood at $73.3 million in 2021, then decreased by 4.09% to $70.3 million in 2022, then rose by 10.23% to $77.5 million in 2023, then climbed by 6.87% to $82.8 million in 2024, then climbed by 19.79% to $86.8 million in 2025.
- Its last three reported values are $86.8 million in Q3 2025, $91.9 million for Q2 2025, and $72.7 million during Q1 2025.